|
1
|
Campo E, Swerdlow SH, Harris NL, Pileri S,
Stein H and Jaffe ES: WHO classification of tumours of
hematopoietic and lymphoid tissues. Blood. 117:5019–5032. 2011.
|
|
2
|
Lossos IS and Morgensztern D: Prognostic
biomarkers in diffuse large B-cell lymphoma. J Clin Oncol.
24:995–1007. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Maxwell SA, Li Z, Jaya D, Ballard S,
Ferrell J and Fu H: 14-3-3zeta mediates resistance of diffuse large
B cell lymphoma to an anthracycline-based chemotherapeutic regimen.
J Biol Chem. 284:22379–22389. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Shipp MA, Ross KN, Tamayo P, et al:
Diffuse large B-cell lymphoma outcome prediction by gene-expression
profiling and supervised machine learning. Nat Med. 8:68–74. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Moss SE and Morgan RO: The annexins.
Genome Biol. 5:2192004. View Article : Google Scholar
|
|
6
|
Laohavisit A and Davies JM:
Multifunctional annexins. Plant Sci. 177:532–539. 2009. View Article : Google Scholar
|
|
7
|
Mussunoor S and Murray GI: The role of
annexins in tumour development and progression. J Pathol.
216:131–140. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Nakao H, Watanabe M and Maki M: A new
function of calphobind I (annexin V). Eur J Biochem. 223:901–908.
1994.PubMed/NCBI
|
|
9
|
Peng B, Guo C, Guan H, Liu S and Sun MZ:
Annexin A5 as a potential marker in tumors. Clin Chim Acta.
427:42–48. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wu X, Tang Y, Huang W, et al:
Identification of proteins interacting with multidrug resistance
protein in gastric cancer. World J Gastroenterol. 19:3568–3573.
2011.
|
|
11
|
Tang S, Huang W, Zhong M, et al:
Identification keratin 1 as a cDDP-resistant protein in
nasopharyngeal carcinoma cell lines. J Proteomics. 75:2352–2360.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Liu Y, Zeng L, Zhang S, Zeng S, Huang J,
Tang Y and Zhong M: Identification of differentially expressed
proteins in chemotherapy-sensitive and chemotherapy-resistant
diffuse large B cell lymphoma by proteomic methods. Med Oncol.
30:5282013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wang B, Feng P, Xiao Z and Ren EC: LIM and
SH3 protein 1 (Lasp1) is a novel p53 transcriptional target
involved in hepato-cellular carcinoma. J Hepatol. 50:528–537. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Feng Y, Hu J, Ma J, et al: RNAi-mediated
silencing of VEGF-C inhibits non-small cell lung cancer progression
by simultaneously down-regulating the CXCR4, CCR7, VEGFR-2 and
VEGFR-3-dependent axes-induced ERK, p38 and AKT signalling
pathways. Eur J Cancer. 47:2353–2363. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Jo YK, Park SJ, Shin JH, Kim Y, Hwang JJ,
Cho DH and Kim JC: ARP101, a selective MMP-2 inhibitor, induces
autophagy-associated cell death in cancer cells. Biochem Biophys
Res Commun. 404:1039–1043. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Qazi H, Shi ZD and Tarbell JM: Fluid shear
stress regulates the invasive potential of glioma cells via
modulation of migratory activity and matrix metalloproteinase
expression. PLoS One. 6:e203482011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Cao CM, Zhang Y, Weisleder N, et al: MG53
constitutes a primary determinant of cardiac ischemic
preconditioning. Circulation. 121:2565–2574. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Fos C, Salles A, Lang V, et al: ICOS
ligation recruits the p50alpha PI3K regulatory subunit to the
immunological synapse. J Immunol. 181:1969–1977. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Li Y, Liao Q, Li K, Zhong D, Weng X and Mi
M: Knockdown of endothelin A receptor expression inhibits
osteosarcoma pulmonary metastasis in an orthotopic xenograft mouse
model. Mol Med Rep. 5:1391–1395. 2012.
|
|
20
|
Li B, Yang Y, Jiang S, Ni B, Chen K and
Jiang L: Adenovirus-mediated overexpression of BMP-9 inhibits human
osteosarcoma cell growth and migration through downregulation of
the PI3K/ AKT pathway. Int J Oncol. 41:1809–1819. 2012.PubMed/NCBI
|
|
21
|
Liu ZL, Mao JH, Peng AF, Yin QS, Zhou Y,
Long XH and Huang SH: Inhibition of fatty acid synthase suppresses
osteo-sarcoma cell invasion and migration via downregulation of the
PI3K/Akt signaling pathway in vitro. Mol Med Rep. 7:608–612.
2013.PubMed/NCBI
|
|
22
|
Zhao G, Cai C, Yang T, et al: MicroRNA-221
induces cell survival and cisplatin resistance through PI3K/Akt
pathway in human osteosarcoma. PLoS One. 8:e539062013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wang TF, Wang H, Peng AF, et al:
Inhibition of fatty acid synthase suppresses U-2 OS cell invasion
and migration via downregulating the activity of HER2/PI3K/AKT
signaling pathway in vitro. Biochem Biophys Res Commun.
440:229–234. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Qin J, Tang J, Jiao L, et al: A
diterpenoid compound, excisanin A, inhibits the invasive behavior
of breast cancer cells by modulating the integrin
β1/FAK/PI3K/AKT/β-catenin signaling. Life Sci. 93:655–663.
2013.PubMed/NCBI
|
|
25
|
Lin G, Sun L, Wang R, Guo Y and Xie C:
Overexpression of muscarinic receptor 3 promotes metastasis and
predicts poor prognosis in non-small-cell lung cancer. J Thorac
Oncol. 9:170–178. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Deng S, Wang J, Hou L, et al: Annexin A1,
A2, A4 and A5 play important roles in breast cancer, pancreatic
cancer and laryngeal carcinoma, alone and/or synergistically. Oncol
Lett. 5:107–112. 2013.PubMed/NCBI
|
